Our Pricing

Weight Loss Clinic Oxford: Expert Medical Treatment & Support

Published: 30 September 2026

Finding a trusted weight loss clinic Oxford residents can rely on requires access to qualified prescribers, genuine licensed medications, and transparent pricing. Our UK-registered pharmacy (GPhC 9012511) provides comprehensive weight loss treatment through online clinical assessment, delivering prescription medications including Mounjaro, Wegovy, Saxenda, and Orlistat directly to patients across Oxford and the wider UK. With superintendent pharmacist Tarun Kumar (GPhC 2233073) overseeing clinical standards, we combine convenience with professional medical expertise for safe, effective weight management.

How Does a Weight Loss Clinic Oxford Service Work?

A weight loss clinic Oxford service begins with a comprehensive clinical assessment to determine suitability for prescription medication. Our online consultation takes under three minutes and is reviewed by UK-registered prescribers who evaluate your medical history, current medications, BMI, and weight loss goals. This ensures treatments are prescribed safely and appropriately for your individual circumstances [1].

Once approved, your chosen medication is dispensed from our UK-registered pharmacy and delivered in discreet packaging directly to your Oxford address. Treatment options include GLP-1 receptor agonists like Mounjaro (tirzepatide) and Wegovy (semaglutide), which work by regulating appetite and blood sugar levels, as well as lipase inhibitors like Orlistat that reduce fat absorption. Each medication requires ongoing monitoring through follow-up consultations to track progress and adjust dosing as needed [2].

Our weight loss clinic Oxford model eliminates the need for in-person appointments whilst maintaining full clinical oversight. You receive the same level of professional care as a traditional clinic, with the added convenience of home delivery and flexible consultation times. All prescription medications are sourced from licensed UK manufacturers and meet MHRA quality standards, ensuring you receive genuine, safe treatments [3].

Weight Loss Clinic Oxford Treatment Options Available

Beyond GLP-1 treatments, our weight loss clinic Oxford range includes lipase inhibitors like Orlistat and Xenical, which prevent approximately 30% of dietary fat from being absorbed. These work differently by blocking the enzyme that breaks down fats in the intestine, making them suitable for patients who prefer non-injection options or have contraindications to GLP-1 medications. Orlistat is available from £124.99, providing an accessible entry point for medically supervised weight loss [7].

GLP-1 Receptor Agonists for Weight Management

The most effective prescription treatments available through our weight loss clinic Oxford service are GLP-1 receptor agonists. Mounjaro (tirzepatide) demonstrated average weight loss of 15-20% of body weight in the SURPASS clinical trial programme, making it one of the most potent options currently licensed in the UK [4]. Wegovy (semaglutide) showed average reductions of 12-15% body weight in the STEP trials, whilst Saxenda (liraglutide) typically produces 5-10% weight loss over 56 weeks [5].

These medications work by mimicking natural hormones that regulate appetite and glucose metabolism. Administered via weekly or daily subcutaneous injections, they reduce hunger signals, increase feelings of fullness, and slow gastric emptying. For patients seeking oral alternatives, Wegovy tablets (oral semaglutide) offer similar efficacy without injections, starting from £124.99 at our pharmacy [6].

Weight Loss Clinic Oxford Pricing and Accessibility

Transparent pricing sets our weight loss clinic Oxford service apart from traditional providers. Mounjaro is available from £124.99, Wegovy from £124.99, Saxenda from £124.99, and Orlistat from £124.99. These prices are displayed upfront before consultation, allowing you to make informed decisions without hidden fees or surprise costs. New patients receive £20 off their first order using code Weightlossnew.

Unlike many private weight loss clinics in Oxford that charge separate consultation fees, our clinical assessment is included at no additional cost. You pay only for the medication itself, with prices guaranteed to be the lowest in the UK. This pricing model makes prescription weight loss treatment accessible to more patients whilst maintaining the same clinical standards as high-street pharmacies [8].

All treatments are delivered free across the UK, typically arriving within 1-2 working days in completely discreet packaging. For Oxford residents, this means convenient access to specialist weight loss medications without the time commitment or expense of regular clinic visits. Repeat prescriptions can be managed entirely online, with automatic reminders ensuring continuity of treatment.

Clinical Effectiveness of Weight Loss Clinic Oxford Treatments

For patients using our weight loss clinic Oxford service, realistic expectations are essential. Most people begin seeing results within 4-8 weeks, with maximum weight loss typically occurring between 6-12 months of treatment. Individual responses vary based on starting weight, adherence to dosing schedules, dietary habits, and metabolic factors. Regular monitoring through follow-up consultations allows prescribers to optimise treatment and address any concerns promptly [2].

Evidence-Based Outcomes from Clinical Trials

The treatments available through our weight loss clinic Oxford service are supported by extensive clinical trial data. In the SURPASS-2 trial, patients taking Mounjaro 15mg achieved average weight loss of 12.4kg (21.1% body weight) compared to 2.9kg with placebo over 40 weeks [4]. The STEP-1 trial demonstrated that 68% of participants on Wegovy 2.4mg lost at least 10% of their body weight, with 50% losing 15% or more [5].

These results represent significant improvements over lifestyle modification alone, which typically produces 3-5% weight loss. However, medications work best when combined with dietary changes and increased physical activity. Our prescribers provide guidance on sustainable lifestyle modifications that enhance treatment effectiveness and support long-term weight maintenance after medication is discontinued [1].

Safety and Side Effects in Weight Loss Clinic Oxford Care

Orlistat carries different side effects related to its mechanism of action, including oily stools, faecal urgency, and flatulence. These are minimised by following a reduced-fat diet (less than 30% of calories from fat). Our weight loss clinic Oxford team provides detailed guidance on managing side effects for all medications, ensuring patients feel supported throughout their treatment journey. All prescription treatments require ongoing clinical monitoring to ensure safety and effectiveness [8].

Common Side Effects and Management Strategies

GLP-1 medications prescribed through our weight loss clinic Oxford service commonly cause gastrointestinal side effects, particularly during initial weeks of treatment. Nausea, diarrhoea, constipation, and abdominal discomfort affect 20-40% of patients but typically diminish as the body adjusts [6]. Starting with lower doses and gradually increasing (dose titration) minimises these effects whilst maintaining efficacy.

More serious but rare risks include pancreatitis, gallbladder disease, and thyroid tumours (seen in animal studies but not conclusively in humans). Our prescribers screen for contraindications including personal or family history of medullary thyroid carcinoma and multiple endocrine neoplasia syndrome type 2. Patients are advised to report severe abdominal pain, persistent vomiting, or signs of allergic reaction immediately [7].

Why Choose Our Weight Loss Clinic Oxford Alternative

Our online weight loss clinic Oxford service combines the clinical expertise of traditional providers with the convenience and cost-effectiveness of digital healthcare. As a fully registered UK pharmacy (GPhC 9012511) with superintendent pharmacist Tarun Kumar overseeing all clinical processes, we maintain the same regulatory standards as any physical clinic whilst eliminating geographic barriers and appointment scheduling constraints.

Patients benefit from transparent upfront pricing, with Mounjaro from £124.99, Wegovy from £124.99, and Saxenda from £124.99 — guaranteed to be the lowest UK prices. Unlike many Oxford-based clinics that require expensive initial consultations and ongoing appointment fees, our clinical assessment is included at no additional cost. This pricing transparency allows you to budget accurately for weight loss treatment without financial surprises.

Every medication is sourced from licensed UK manufacturers and dispensed by qualified pharmacists, ensuring you receive genuine, safe treatments. Our clinical team is available via phone (+44 116 4646009) for any questions or concerns, providing the personalised support you would expect from a traditional weight loss clinic Oxford facility. With discreet home delivery and online prescription management, we offer a modern, accessible approach to medically supervised weight loss that fits seamlessly into busy Oxford lifestyles.

Scientific References

1. National Institute for Health and Care Excellence. (2023). Weight management: lifestyle services for overweight or obese adults (PH53). NICE. [accessed 30 September 2026]
2. Garvey, W. T., Batterham, R. L., Bhatta, M., et al. (2022). Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial. Nature Medicine, 28(10), 2083-2091. [accessed 30 September 2026]
3. Medicines and Healthcare products Regulatory Agency. (2023). Good practice guidance for healthcare professionals and patients on the safe use of GLP-1 receptor agonists. MHRA. [accessed 30 September 2026]
4. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine, 387(3), 205-216. [accessed 30 September 2026]
5. Wilding, J. P., Batterham, R. L., Calanna, S., et al. (2021). Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine, 384(11), 989-1002. [accessed 30 September 2026]
6. Knop, F. K., Aroda, V. R., do Vale, R. D., et al. (2023). Oral semaglutide 50 mg taken once per day in adults with overweight or obesity (OASIS 1): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet, 402(10403), 705-719. [accessed 30 September 2026]
7. Torgerson, J. S., Hauptman, J., Boldrin, M. N., & Sjöström, L. (2004). XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care, 27(1), 155-161. [accessed 30 September 2026]
8. General Pharmaceutical Council. (2023). Standards for registered pharmacies. GPhC. [accessed 30 September 2026]
9. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 30 September 2026.
10. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 30 September 2026.
11. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 30 September 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.